These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
394 related items for PubMed ID: 16597632
1. Evolution of multidrug-resistant Acinetobacter baumannii isolates obtained from elderly patients with respiratory tract infections. Canduela MJ, Gallego L, Sevillano E, Valderrey C, Calvo F, Pérez J. J Antimicrob Chemother; 2006 Jun; 57(6):1220-2. PubMed ID: 16597632 [Abstract] [Full Text] [Related]
2. Clusters of imipenem-resistant Acinetobacter baumannii clones producing different carbapenemases in an intensive care unit. Tsakris A, Ikonomidis A, Poulou A, Spanakis N, Vrizas D, Diomidous M, Pournaras S, Markou F. Clin Microbiol Infect; 2008 Jun; 14(6):588-94. PubMed ID: 18397334 [Abstract] [Full Text] [Related]
3. Emergence of carbapenem resistance in Acinetobacter baumannii in the Czech Republic is associated with the spread of multidrug-resistant strains of European clone II. Nemec A, Krízová L, Maixnerová M, Diancourt L, van der Reijden TJ, Brisse S, van den Broek P, Dijkshoorn L. J Antimicrob Chemother; 2008 Sep; 62(3):484-9. PubMed ID: 18477708 [Abstract] [Full Text] [Related]
4. Dissemination of multidrug-resistant Acinetobacter baumannii genotypes carrying bla(OXA-23) collected from hospitals in Rio de Janeiro, Brazil. Carvalho KR, Carvalho-Assef AP, Peirano G, Santos LC, Pereira MJ, Asensi MD. Int J Antimicrob Agents; 2009 Jul; 34(1):25-8. PubMed ID: 19216059 [Abstract] [Full Text] [Related]
5. [Molecular mechanism of multiple-drug and pan-drug resistance among Acinetobacter species]. Wang H, Sun HL, Ning YZ, Yang QW, Chen MJ, Zhu YJ, Xu YC, Xie XL. Zhonghua Yi Xue Za Zhi; 2006 Jan 03; 86(1):17-22. PubMed ID: 16606529 [Abstract] [Full Text] [Related]
6. Outbreak of multiple clones of imipenem-resistant Acinetobacter baumannii isolates expressing OXA-58 carbapenemase in an intensive care unit. Pournaras S, Markogiannakis A, Ikonomidis A, Kondyli L, Bethimouti K, Maniatis AN, Legakis NJ, Tsakris A. J Antimicrob Chemother; 2006 Mar 03; 57(3):557-61. PubMed ID: 16431857 [Abstract] [Full Text] [Related]
7. Dissemination of multidrug-resistant, class 1 integron-carrying Acinetobacter baumannii isolates in Taiwan. Huang LY, Chen TL, Lu PL, Tsai CA, Cho WL, Chang FY, Fung CP, Siu LK. Clin Microbiol Infect; 2008 Nov 03; 14(11):1010-9. PubMed ID: 19040472 [Abstract] [Full Text] [Related]
8. Temporal evolution of carbapenem-resistant Acinetobacter baumannii in Curitiba, southern Brazil. Schimith Bier KE, Luiz SO, Scheffer MC, Gales AC, Paganini MC, Nascimento AJ, Carignano E, Dalla Costa LM. Am J Infect Control; 2010 May 03; 38(4):308-14. PubMed ID: 20123152 [Abstract] [Full Text] [Related]
9. IMP-4 and OXA beta-lactamases in Acinetobacter baumannii from Singapore. Koh TH, Sng LH, Wang GC, Hsu LY, Zhao Y. J Antimicrob Chemother; 2007 Apr 03; 59(4):627-32. PubMed ID: 17284537 [Abstract] [Full Text] [Related]
10. Antimicrobial susceptibility patterns and distribution of blaOXA genes among Acinetobacter spp. Isolated from patients at Tehran hospitals. Feizabadi MM, Fathollahzadeh B, Taherikalani M, Rasoolinejad M, Sadeghifard N, Aligholi M, Soroush S, Mohammadi-Yegane S. Jpn J Infect Dis; 2008 Jul 03; 61(4):274-8. PubMed ID: 18653968 [Abstract] [Full Text] [Related]
14. Molecular epidemiology of clinical isolates of carbapenem-resistant Acinetobacter spp. from Chinese hospitals. Wang H, Guo P, Sun H, Wang H, Yang Q, Chen M, Xu Y, Zhu Y. Antimicrob Agents Chemother; 2007 Nov 03; 51(11):4022-8. PubMed ID: 17846127 [Abstract] [Full Text] [Related]
15. Characterization of acquired beta-lactamases and their genetic support in multidrug-resistant Pseudomonas aeruginosa isolates in Taiwan: the prevalence of unusual integrons. Yan JJ, Hsueh PR, Lu JJ, Chang FY, Ko WC, Wu JJ. J Antimicrob Chemother; 2006 Sep 03; 58(3):530-6. PubMed ID: 16816399 [Abstract] [Full Text] [Related]
16. Molecular characterisation of multiple drug-resistant Acinetobacter baumannii isolates in southern Taiwan. Ben RJ, Yang MC, Hsueh JC, Shiang JC, Chien ST. Int J Antimicrob Agents; 2011 Nov 03; 38(5):403-8. PubMed ID: 21871784 [Abstract] [Full Text] [Related]
17. Characterisation and clonal dissemination of OXA-23-producing Acinetobacter baumannii in Tabriz, northwest Iran. Peymani A, Higgins PG, Nahaei MR, Farajnia S, Seifert H. Int J Antimicrob Agents; 2012 Jun 03; 39(6):526-8. PubMed ID: 22521767 [Abstract] [Full Text] [Related]
19. Two distinct clones of carbapenem-resistant Acinetobacter baumannii isolates from Korean hospitals. Park YK, Choi JY, Jung SI, Park KH, Lee H, Jung DS, Heo ST, Kim SW, Chang HH, Cheong HS, Chung DR, Peck KR, Song JH, Ko KS. Diagn Microbiol Infect Dis; 2009 Aug 03; 64(4):389-95. PubMed ID: 19631092 [Abstract] [Full Text] [Related]
20. Detection of OXA-type carbapenemases and integrons among carbapenem-resistant Acinetobactor baumannii in a teaching hospital in China. Hu Q, Hu Z, Li J, Tian B, Xu H, Li J. J Basic Microbiol; 2011 Oct 03; 51(5):467-72. PubMed ID: 21656808 [Abstract] [Full Text] [Related] Page: [Next] [New Search]